Trump's vaccine team will not brief Biden administration - U.S senator


  • World
  • Friday, 20 Nov 2020

FILE PHOTO: U.S. Democratic Senator Chris Murphy (D-CT) attends a news conference about the results in the 2020 U.S. presidential election, on Capitol Hill in Washington, U.S., November 10, 2020. REUTERS/Hannah McKay/File Photo

WASHINGTON (Reuters) - Officials from President Donald Trump's vaccine distribution effort have not briefed anyone on President-elect Joe Biden's transition team, and have no plans to do so, a Democratic U.S. senator said after a White House call Thursday.

"Just off a conference call with Trump Administration vaccine distribution team," Senator Chris Murphy said on Twitter. "They confirmed that they have not briefed anyone on President-elect Biden's team and have no plans to do so. This is potentially catastrophic."

The call, for all senators, was conducted on Thursday morning by General Gustave Perna and Dr. Moncef Slaoui, leaders https://www.hhs.gov/about/news/2020/05/15/trump-administration-announces-framework-and-leadership-for-operation-warp-speed.html of "Operation Warp Speed," the administration's vaccine-development effort, a Congressional aide said.

Asked for comment, White House spokesman Brian Morgenstern did not address whether Biden's team would be briefed, saying vaccine distribution plans from the Centers for Disease Control and state governors were publicly available.

"Manufacturing is well underway, and Dr. Slaoui confirmed that 20 million Americans are on track for vaccinations in December with tens of millions per month thereafter," Morgenstern said.

A wave of coronavirus infection has gripped the United States and the death toll surpassed 250,000 this week. A vaccine may be available in the coming months, but distributing it to over 300 million Americans might be complicated by special storage and transport conditions.

Biden said on Wednesday that a range of information had not been made available to his campaign, including the distribution plan for COVID-19 vaccines. His administration is scheduled to take over the U.S. government on Jan. 20, when he is inaugurated.

Failure to promptly share critical COVID-19 data with Biden's team will cause needless, deadly delays in tackling the pandemic, leaders of the U.S. medical establishment said in a letter to Trump Tuesday.

Biden's transition team did not immediately respond to a request for comment.

Emily Murphy, administrator of the General Services Administration, a generally little-known agency that keeps the U.S. government running, has so far refused to "ascertain" the winner of the Nov. 3 presidential election between Biden and Trump, a condition for releasing funds and resources to the winner.

Despite a clear margin of victory for Biden, Trump has refused to concede, and his legal challenges are fizzling. But he has been backed up by many of his fellow Republicans, both in Washington and around the country.

(Reporting by Patricia Zengerle, additional reporting by Steve Holland,; Editing by Heather Timmons and Alistair Bell)

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3
   

Did you find this article insightful?

Yes
No

73% readers found this article insightful

Next In World

New Zealand, Taiwan top COVID performance ranking, U.S., UK languish
U.S. will stand with Southeast Asian countries against Chinese pressure: Blinken
Mexican president progressing well with minor symptoms after COVID-19 diagnosis, minister says
Walmart to build more robot-filled warehouses at stores
Singapore detains teen for intending to attack mosques
Think your kid’s being bullied online? Don’t just read their messages
Australian state borders to reopen with zero local virus cases
Thais seek to restore fortunes with mock funerals
Biden polls higher in first week than Trump at any time
Rumours and fear dog Philippine plan for coronavirus vaccine drive

Stories You'll Enjoy


-->